Related to MDxHealth’s MGMT Methylation Test Selected for Phase III Brain Cancer Trial

• 
• Methylation Analysis
• Zymo Research
• The EZ DNA Methylation-Lightning kit is for complete bisulfite conversion of DNA prior to methylation analysis by PCR, MSP, array, or next-gen sequencing. The ready-to-use liquid-format Lightning conversion reagent is added directly to a DNA sample
• 
• BRAF Mutation Detection
• Swift Biosciences
• myT BRAF-Ultra, an ultrasensitive version of myT BRAF, provides 0.01% sensitivity down to single-copy detection of BRAF mutations. myT BRAF-Ultra can detect less than 10 copies of mutant BRAF V600E/K with low breakthrough amplification from a backg
• 
• Microplate Detection Platform
• Molecular Devices
• The SpectraMax i3 platform’s base system features an integrated optical system enabling top and bottom reads for 6–384-well microplates and launches with three detection modes: luminescence, absorbance, and fluorescence. The user-exchangeable cartr
• 
• Epigenetics Conjugates
• Cisbio Bioassays
• The epigenetics toolbox is a selection of conjugates specifically developed for epigenetics studies to help pharmaceutical and biotechnology researchers better understand how these events occur through epigenetic mechanisms and how they relate
• 
• Methylated Gene Targeting
• Cellectis bioresearch
• TALEN™ CpG™ is a service designed to overcome the impact of methylated DNA on TALEN nuclease activity. Users can target any gene at any position in any cell type regardless of methylation status. The service can make gene editing accessible for the